January 30, 2018

PET-Adapted Therapy Effective in Hodgkin Lymphoma

Investigators successfully used PET/CT scanning to determine whether patients with stage IIB to IVB Hodgkin lymphoma should switch from ABVD to BEACOPP, according to updated results from the international GITIL/FIL HD 0607 trial published in the Journal of Clinical Oncology. {read more here}